Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proteome-based Immunotherapy for Brain Metastases from Breast Cancer
NCT01782274Phase 3Unknown
- Sponsor
- NeuroVita Clinic
- Start
- Dec 2012
- Primary completion
- Dec 2018
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic hematopoietic stem cells, WT1/hTERT/Survivin-loaded dendritic cell vaccine in breast cancer, sponsored by NeuroVita Clinic. Status: unknown.
02
Drugs
allogeneic hematopoietic stem cellsWT1/hTERT/Survivin-loaded dendritic cell vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01782274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782274.